Wen Jizhi, Jia Shuangshuang, Wang Zhen, Chen Jingwang, Liang Qianni, Wei Ling, Richard Gaëlle, Fichou Yann, Luo Guangping, Ji Yanli
Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China.
The Key Medical Laboratory of Guangzhou, Guangzhou, People's Republic of China.
Transfusion. 2023 Feb;63(2):402-414. doi: 10.1111/trf.17186. Epub 2022 Nov 16.
The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.
Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population. A special three-step typing strategy was applied. First, the common DVI type 3 was identified from epitope profiles of D antigen. Then, another common weak D type 15 (RHD*845A) was identified by epitope profiles of D antigen and Sanger sequencing of RHD exon 6. Finally, the remaining D variants were genotyped mainly by Sanger sequencing. For the novel RHD alleles in the coding region and exon-intron junction, in vitro transfection and minigene splicing assays were performed, respectively. The anti-D investigation was performed.
DVI type 3 (65/253, 25.7%) and weak D type 15 (62/253, 24.5%) were common Chinese D variants, and RHD960A, DFR, RHDweak D type 25, 72, and 136 were frequent variant RHD alleles. Besides, twenty-two sporadic and seven novel RHD alleles (RHD188A; RHD688C; RHD782 T; RHD1181C; RHD165 T, 993A; RHD148 + 3G > T and RHD*1227 + 5G > C) were identified. The deleterious effect of the novel RHD alleles on D antigen or mRNA expression was confirmed. Anti-D was detected in two DVI type 3 pregnant women.
The three-step typing strategy provides an effective approach for Chinese D variant typing. It can be anticipated that commercially available RHD genotyping kits have limitations for testing Chinese D variants, as some of the frequent variants are not interrogated.
中国人D变异型表型的分子基础与白种人大不相同。有必要针对常见的RHD变异等位基因谱采用特定的D分型策略。
收集中国南方人群中D表型不明确的血样。应用一种特殊的三步分型策略。首先,从D抗原的表位谱中鉴定出常见的DVI 3型。然后,通过D抗原的表位谱和RHD外显子6的桑格测序鉴定出另一种常见的弱D 15型(RHD*845A)。最后,其余的D变异型主要通过桑格测序进行基因分型。对于编码区和外显子-内含子交界处的新型RHD等位基因,分别进行了体外转染和小基因剪接试验。进行了抗-D检测。
DVI 3型(65/253,25.7%)和弱D 15型(62/253,24.5%)是常见的中国D变异型,RHD960A、DFR、RHD弱D 25型、72型和136型是常见的变异RHD等位基因。此外,还鉴定出22个散发性和7个新型RHD等位基因(RHD188A;RHD688C;RHD782T;RHD1181C;RHD165T,993A;RHD148+3G>T和RHD*1227+5G>C)。证实了新型RHD等位基因对D抗原或mRNA表达的有害作用。在两名DVI 3型孕妇中检测到了抗-D。
三步分型策略为中国D变异型分型提供了一种有效的方法。可以预见,市售的RHD基因分型试剂盒在检测中国D变异型方面存在局限性,因为一些常见变异未被检测到。